NxThera, Inc. markets a minimally invasive treatment for enlarged prostate and prostate cancer.
Acquired by Boston Scientific, April 2018
NxThera, Inc. markets a minimally invasive treatment for enlarged prostate and prostate cancer.
Acquired by Boston Scientific, April 2018
© 2025 Arboretum Ventures. Privacy Policy | Cookie Policy | Terms Policy